WeConfort Supplement for Dogs | 30 Tablets

Pets now have longer life expectancies due to advances in veterinary care. As a result, there is an increased prevalence of chronic conditions associated with pain and loss of sensory capabilities. Chronic pain affects the health and well-being of our animals and has a negative impact on their quality of life.

Chronic pain is characterized by mixed nociceptive input stimuli and does not have a clear endpoint or physiological function.

WeConfort® promotes the vitality and general well-being of dogs and cats, in different situations:
? Geriatric animals, where there is a deficit in sensory functions;
? Animals that present processes that lead to chronic pain states;
? Animals exposed to conditions of high oxidative stress;
? Animals that demonstrate chronic states of tiredness or fatigue;
? All situations of chronic pain associated with osteoarthritis, especially those controlled only with the use of NSAIDs. Complementary compound food for dogs and cats developed for nutritional support of sensory function and for promoting general well-being, particularly in the control of processes related to pain and inflammation. Cannabis Sativa ? Hemp Oil
Hemp Oil contains cannabidiol (CBD) with modulating activity on the Endocannabinoid System - ECS. In situations of pain associated with inflammation or hyperalgesia, exogenous cannabinoids, such as CBD, produce different levels of analgesia. In addition to all the functions associated with the Endocannabinoid System, Hemp Oil has a high concentration of essential fatty acids, functioning as a potent antioxidant.

Harpagophytum procumbens
WeConfort® contains a Concentrated Dry Extract of Harpagophytum, resulting from the elimination of “impurities” and concentration of the active nutraceutical molecule. It has anti-inflammatory and analgesic properties, particularly in the treatment of painful joint manifestations. Studies indicate that it can inhibit both pathways of arachidonic acid metabolism, the cyclooxygenase (COX) pathway and the lipoxygenase (LOX) pathway, reducing the production of eicosanoids such as prostaglandins. Regarding the inhibition of the COX pathway, harpagophytum appears to specifically inhibit COX-2, but not COX-1, which may explain its high tolerance and reduced side effects, unlike old NSAIDs that inhibit nonspecific isoforms of the enzyme.

Omega 3 (Concentrated in EPA) ?3
Nowadays, through technological processes, it is possible to separate the different substances that make up Omega 3, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Recent studies associate DHA with the support of degenerative processes, while EPA with different metabolic processes in which the inflammatory component is critical. EPA supplementation has shown positive effects on lipid metabolism, suppression of body fat accumulation, reduction of insulin resistance and hepatic steatosis. The administration of EPA promotes the synthesis of anti-inflammatory eicosanoids, such as prostaglandin PG-3 and leukotriene LT-5, and reduces the synthesis of other highly inflammatory eicosanoids.